JP2021523119A5 - - Google Patents

Info

Publication number
JP2021523119A5
JP2021523119A5 JP2020561734A JP2020561734A JP2021523119A5 JP 2021523119 A5 JP2021523119 A5 JP 2021523119A5 JP 2020561734 A JP2020561734 A JP 2020561734A JP 2020561734 A JP2020561734 A JP 2020561734A JP 2021523119 A5 JP2021523119 A5 JP 2021523119A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
liposomes
disease
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020561734A
Other languages
English (en)
Japanese (ja)
Other versions
JP7355394B2 (ja
JP2021523119A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030625 external-priority patent/WO2019213538A1/en
Publication of JP2021523119A publication Critical patent/JP2021523119A/ja
Publication of JP2021523119A5 publication Critical patent/JP2021523119A5/ja
Priority to JP2023148278A priority Critical patent/JP7555630B2/ja
Application granted granted Critical
Publication of JP7355394B2 publication Critical patent/JP7355394B2/ja
Priority to JP2024152342A priority patent/JP2024163254A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561734A 2018-05-03 2019-05-03 カロテノイド組成物およびその使用 Active JP7355394B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023148278A JP7555630B2 (ja) 2018-05-03 2023-09-13 カロテノイド組成物およびその使用
JP2024152342A JP2024163254A (ja) 2018-05-03 2024-09-04 カロテノイド組成物およびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862666699P 2018-05-03 2018-05-03
US62/666,699 2018-05-03
US201962809123P 2019-02-22 2019-02-22
US62/809,123 2019-02-22
PCT/US2019/030625 WO2019213538A1 (en) 2018-05-03 2019-05-03 Carotenoid compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023148278A Division JP7555630B2 (ja) 2018-05-03 2023-09-13 カロテノイド組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2021523119A JP2021523119A (ja) 2021-09-02
JP2021523119A5 true JP2021523119A5 (https=) 2022-05-13
JP7355394B2 JP7355394B2 (ja) 2023-10-03

Family

ID=68386961

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020561734A Active JP7355394B2 (ja) 2018-05-03 2019-05-03 カロテノイド組成物およびその使用
JP2023148278A Active JP7555630B2 (ja) 2018-05-03 2023-09-13 カロテノイド組成物およびその使用
JP2024152342A Pending JP2024163254A (ja) 2018-05-03 2024-09-04 カロテノイド組成物およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023148278A Active JP7555630B2 (ja) 2018-05-03 2023-09-13 カロテノイド組成物およびその使用
JP2024152342A Pending JP2024163254A (ja) 2018-05-03 2024-09-04 カロテノイド組成物およびその使用

Country Status (11)

Country Link
US (2) US12458597B2 (https=)
EP (2) EP4667017A3 (https=)
JP (3) JP7355394B2 (https=)
KR (2) KR102877117B1 (https=)
CN (2) CN119185280A (https=)
AU (2) AU2019262189B2 (https=)
BR (1) BR112020022077A2 (https=)
CA (1) CA3098868A1 (https=)
ES (1) ES3063369T3 (https=)
MX (2) MX2020011662A (https=)
WO (1) WO2019213538A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018501322A (ja) 2015-01-12 2018-01-18 チルドレンズ メディカル センター コーポレーション トール様受容体4アンタゴニストの炎症促進性およびアジュバント機能
JP7355394B2 (ja) 2018-05-03 2023-10-03 エル.イー.エー.エフ. ホールディングス グループ エルエルシー カロテノイド組成物およびその使用
WO2021091862A1 (en) * 2019-11-06 2021-05-14 L.E.A.F. Holdings Group Llc Carotenoid compositions and uses thereof
CN114980919B (zh) * 2019-11-18 2026-04-14 儿童医学中心公司 过度活化驻留树突状细胞的刺激物用于癌症免疫疗法
EP4125857A4 (en) * 2020-03-31 2024-04-17 Diffusion Pharmaceuticals LLC USE OF DIFFUSION ENHANCEMENT COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASE INDUCED BY VIRUSES AND BACTERIA
WO2021207566A1 (en) * 2020-04-09 2021-10-14 L.E.A.F. Holdings Group Llc Carotenoid solutions and uses thereof
US20230134835A1 (en) * 2020-04-09 2023-05-04 L.E.A.F. Holdings Group Llc Methods of synthesizing carotenoids
WO2021207650A1 (en) * 2020-04-09 2021-10-14 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens
WO2021207690A1 (en) * 2020-04-09 2021-10-14 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens
US20230277494A1 (en) * 2020-07-27 2023-09-07 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens
US20230270706A1 (en) * 2020-07-27 2023-08-31 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens
JP2023169444A (ja) * 2020-10-01 2023-11-30 株式会社Epsilon Molecular Engineering 標的タンパク質と結合し得る架橋ペプチド、当該架橋ペプチドの作製方法、及び当該架橋ペプチドを有効成分とする医薬組成物
WO2022150716A1 (en) * 2021-01-10 2022-07-14 Diffusion Pharmaceuticals Llc Methods of treating wounds and burns
EP4337101A4 (en) * 2021-05-10 2025-06-25 L.E.A.F Holdings Group LLC Methods and compositions for the treatment of aging and chronic diseases
WO2023029041A1 (zh) * 2021-09-06 2023-03-09 北京茵诺医药科技有限公司 靶向动脉粥样硬化脂质体纳米载体递送系统及其制备方法
CN114748461B (zh) * 2022-04-29 2023-03-21 合肥工业大学 一种藏红花酸制剂及其应用
CN114699396A (zh) * 2022-04-29 2022-07-05 合肥工业大学 藏红花酸作为抗疲劳成分在药物和食品方面的应用
US12128019B1 (en) 2023-06-15 2024-10-29 King Faisal University Nanocomposite including abscisic acid-loaded collagen nanoparticles
JP2025052190A (ja) 2023-09-25 2025-04-07 株式会社日立製作所 アンモニア合成触媒及びその製造方法
KR20250173014A (ko) 2024-05-30 2025-12-10 국립부경대학교 산학협력단 카로티노이드를 포함하는 근육 질환의 예방 및 치료용 약학 조성물
CN119081927B (zh) * 2024-08-28 2025-08-22 青岛日晟源作物营养有限公司 一株暹罗芽孢杆菌sl-k1及其菌根素提取物的制备方法和应用

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840532A (en) * 1953-07-17 1958-06-24 Universal Oil Prod Co Alumina platinum catalyst and preparation thereof
US4699664A (en) * 1985-05-01 1987-10-13 Nestec S.A. Stabilized natural pigment complexes
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US6060511A (en) * 1995-10-05 2000-05-09 Gainer; John L. Trans-sodium crocetinate, methods of making and methods of use thereof
US20030073640A1 (en) 1997-07-23 2003-04-17 Ribozyme Pharmaceuticals, Inc. Novel compositions for the delivery of negatively charged molecules
WO2000030444A1 (en) 1998-11-25 2000-06-02 Vanderbilt University Cationic liposomes for gene transfer
IL156976A0 (en) * 2001-02-13 2004-02-08 Yissum Res Dev Co Carotenoid-loaded liposomes
CA2477245A1 (en) 2002-02-25 2003-09-04 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) * 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
DE60334295D1 (de) 2002-05-23 2010-11-04 3M Innovative Properties Co Elektronische baugruppe und verfahren zur herstellung einer elektronischen baugruppe
FR2840532B1 (fr) * 2002-06-11 2005-05-06 Ethypharm Sa Nanocapsules lipidiques furtives, procede de preparation et utilisation comme vecteur de principes(s) actif(s)
AU2003256264A1 (en) 2002-06-04 2003-12-19 California Institute Of Technology Carotenoid synthesis
CN101845009B (zh) * 2002-07-29 2012-10-03 卡达克斯药物公司 用于抑制和改善疾病的类胡萝卜素结构类似物
GB0314624D0 (en) * 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
CA2537210C (en) 2003-08-25 2013-06-04 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US20080025929A1 (en) * 2004-02-19 2008-01-31 Chemaphor, Inc. Topical Formulations for the Treatment of Skin Conditions
WO2006074416A1 (en) 2005-01-07 2006-07-13 Health Research Inc. 5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
US7404969B2 (en) 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
WO2007086881A2 (en) 2005-02-14 2007-08-02 Sirna Therapeutics, Inc. Cationic lipids and formulated molecular compositions containing them
EP2540696B1 (en) 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
WO2006102576A1 (en) 2005-03-23 2006-09-28 Cardax Pharmaceuticals, Inc. Water-dispersible carotenoids, including analogs and derivatives
ATE492165T1 (de) * 2005-05-23 2011-01-15 Phares Drug Delivery Ag Direkte lösung
WO2007147163A2 (en) 2006-06-16 2007-12-21 Cardax Pharmaceuticals, Inc. Compositions comprising carotenoid analogs or derivatives and methods for synthesis
CA2689042A1 (en) 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
US20080213352A1 (en) * 2007-03-02 2008-09-04 Luna Innovations Incorporated Liposome carriers for in vivo delivery of fullerenes
JP5191764B2 (ja) * 2007-03-30 2013-05-08 理研ビタミン株式会社 睡眠改善剤
WO2010021865A1 (en) 2008-08-18 2010-02-25 Merck Sharp & Dohme Corp. Novel lipid nanoparticles and novel components for delivery of nucleic acids
WO2010080724A1 (en) 2009-01-12 2010-07-15 Merck Sharp & Dohme Corp. Novel lipid nanoparticles and novel components for delivery of nucleic acids
JP2009179628A (ja) 2009-01-16 2009-08-13 Tsujido Chemical Corp 養毛・育毛剤
US8569256B2 (en) 2009-07-01 2013-10-29 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
WO2011000107A1 (en) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Novel lipid formulations for delivery of therapeutic agents to solid tumors
ES2579936T3 (es) 2009-08-20 2016-08-17 Sirna Therapeutics, Inc. Nuevos lípidos catiónicos con diversos grupos de cabeza para el suministro oligonucleotídico
US20110054543A1 (en) * 2009-08-31 2011-03-03 Warsaw Orthopedic, Inc. Locking mechanism
EP2485770A4 (en) 2009-10-08 2013-04-10 Merck Sharp & Dohme Novel cationic lipids with short lipid chains for oligonucleotide delivery
EP2525781A1 (en) 2010-01-22 2012-11-28 Schering Corporation Novel cationic lipids for oligonucleotide delivery
CN101811956B (zh) * 2010-04-15 2013-04-17 施冬云 反式西红花酸的制备方法
US8802863B2 (en) 2010-05-24 2014-08-12 Sirna Therapeutics, Inc. Amino alcohol cationic lipids for oligonucleotide delivery
AU2011262361A1 (en) 2010-06-02 2013-01-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
DK2575767T3 (en) 2010-06-04 2017-03-13 Sirna Therapeutics Inc HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES
KR101761388B1 (ko) 2010-07-30 2017-07-25 큐어백 아게 트랜스펙션 및 면역 자극을 위한 이황화-크로스링크된 양이온 성분 및 핵산의 복합체
CA2809858C (en) 2010-09-20 2019-11-12 Sirna Therapeutics, Inc. Novel low molecular weight cationic lipids for oligonucleotide delivery
CA2811430A1 (en) 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Low molecular weight cationic lipids for oligonucleotide delivery
EP3485913A1 (en) 2010-10-21 2019-05-22 Sirna Therapeutics, Inc. Low molecular weight cationic lipids for oligonucleotide delivery
WO2012061259A2 (en) 2010-11-05 2012-05-10 Merck Sharp & Dohme Corp. Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
GB201101669D0 (en) 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof
ES2795110T3 (es) 2011-06-08 2020-11-20 Translate Bio Inc Lípidos escindibles
CN103183603A (zh) 2011-12-30 2013-07-03 江苏天晟药业有限公司 藏红花酸有机胺盐及其制备方法
CN104684546A (zh) * 2012-06-07 2015-06-03 哈佛大学校长及研究员协会 用于药物靶向的纳米疗法
US9211298B2 (en) 2012-11-16 2015-12-15 Song Gao Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
IL252192B2 (en) 2014-11-10 2024-03-01 Del Mar Pharmaceuticals Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiforme
FR3035589B1 (fr) 2015-04-30 2019-12-13 Biophytis Composition pour la protection des cellules de l'epithelium pigmentaire retinien
CA3018550A1 (en) * 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
CN105935363B (zh) * 2016-04-29 2017-03-08 暨南大学 组合物、藏红花色素类活性部位及其用途
CN107753427B (zh) * 2016-08-18 2022-01-14 上海交通大学 一种全反式维甲酸脂质体制剂及其制备与应用
JP7355394B2 (ja) 2018-05-03 2023-10-03 エル.イー.エー.エフ. ホールディングス グループ エルエルシー カロテノイド組成物およびその使用
WO2021091862A1 (en) 2019-11-06 2021-05-14 L.E.A.F. Holdings Group Llc Carotenoid compositions and uses thereof
US20230134835A1 (en) 2020-04-09 2023-05-04 L.E.A.F. Holdings Group Llc Methods of synthesizing carotenoids
WO2021207566A1 (en) 2020-04-09 2021-10-14 L.E.A.F. Holdings Group Llc Carotenoid solutions and uses thereof
WO2021207690A1 (en) 2020-04-09 2021-10-14 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens
WO2021207650A1 (en) 2020-04-09 2021-10-14 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens
US20230270706A1 (en) 2020-07-27 2023-08-31 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens
US20230277494A1 (en) 2020-07-27 2023-09-07 L.E.A.F. Holdings Group Llc Trans-crocetin compositions and treatment regimens

Similar Documents

Publication Publication Date Title
JP2021523119A5 (https=)
JP2025072362A5 (https=)
JP2019524885A5 (https=)
JP2019524802A5 (https=)
JP2021513550A5 (https=)
JP2021512895A5 (https=)
JP2021513528A5 (https=)
JP2021513531A5 (https=)
JP7555630B2 (ja) カロテノイド組成物およびその使用
US11207428B2 (en) Cross-linked polymer modified nanoparticles
JP2021514357A5 (https=)
JP2021513529A5 (https=)
CN105968373B (zh) 一种含两性离子的多重酸敏感抗肿瘤载药胶束及其制备方法和应用
JP2021513533A5 (https=)
US11103588B2 (en) Methods and compositions relating to carnitine-derived materials
CN116171150A (zh) 冻干脂质纳米颗粒的方法
JP2012503603A5 (https=)
Lenders et al. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport
JP2017505104A5 (https=)
JP2019533645A5 (https=)
JP2014505685A5 (https=)
JP2009512696A (ja) 標的化イムノリポソームの調製法
CN103342788A (zh) 三嵌段聚阳离子、其制备方法及用途
WO2011135734A1 (ja) ウイルスの複合体、それを含有する治療薬及び治療方法
JP2010173990A (ja) 遺伝子治療剤